{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:37:57Z","timestamp":1793151477310,"version":"4.5.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2013,11,8]],"date-time":"2013-11-08T00:00:00Z","timestamp":1383868800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1038\/pr.2013.187","type":"journal-article","created":{"date-parts":[[2013,11,8]],"date-time":"2013-11-08T16:52:49Z","timestamp":1383929569000},"page":"176-183","source":"Crossref","is-referenced-by-count":50,"title":["Advances in the pathogenesis and treatment of systemic juvenile idiopathic arthritis"],"prefix":"10.1038","volume":"75","author":[{"given":"Colleen K.","family":"Correll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryce A.","family":"Binstadt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,8]]},"reference":[{"key":"BFpr2013187_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/095952879708000106","volume":"80","author":"GF Still","year":"1897","unstructured":"Still GF . On a Form of Chronic Joint Disease in Children. Med Chir Trans 1897;80:47\u201360.9.","journal-title":"Med Chir Trans"},{"key":"BFpr2013187_CR2","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, et al.; International League of Associations for Rheumatology. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004;31:390\u20132.","journal-title":"J Rheumatol"},{"key":"BFpr2013187_CR3","first-page":"1377","volume":"33","author":"S Danner","year":"2006","unstructured":"Danner S, Sordet C, Terzic J, et al. Epidemiology of juvenile idiopathic arthritis in Alsace, France. J Rheumatol 2006;33:1377\u201381.","journal-title":"J Rheumatol"},{"key":"BFpr2013187_CR4","first-page":"2275","volume":"30","author":"L Berntson","year":"2003","unstructured":"Berntson L, Andersson G\u00e4re B, Fasth A, et al.; Nordic Study Group. Incidence of juvenile idiopathic arthritis in the Nordic countries. A population based study with special reference to the validity of the ILAR and EULAR criteria. J Rheumatol 2003;30:2275\u201382.","journal-title":"J Rheumatol"},{"key":"BFpr2013187_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1442-200X.1997.tb03593.x","volume":"39","author":"S Fujikawa","year":"1997","unstructured":"Fujikawa S, Okuni M . Clinical analysis of 570 cases with juvenile rheumatoid arthritis: results of a nationwide retrospective survey in Japan. Acta Paediatr Jpn 1997;39:245\u20139.","journal-title":"Acta Paediatr Jpn"},{"key":"BFpr2013187_CR6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/BF02751521","volume":"63","author":"V Seth","year":"1996","unstructured":"Seth V, Kabra SK, Semwal OP, Jain Y . Clinico-immunological profile in juvenile rheumatoid arthritis\u2013an Indian experience. Indian J Pediatr 1996;63:293\u2013300.","journal-title":"Indian J Pediatr"},{"key":"BFpr2013187_CR7","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.3899\/jrheum.090937","volume":"37","author":"V Kunjir","year":"2010","unstructured":"Kunjir V, Venugopalan A, Chopra A . Profile of Indian patients with juvenile onset chronic inflammatory joint disease using the ILAR classification criteria for JIA: a community-based cohort study. J Rheumatol 2010;37:1756\u201362.","journal-title":"J Rheumatol"},{"key":"BFpr2013187_CR8","first-page":"343","volume":"35","author":"EM Behrens","year":"2008","unstructured":"Behrens EM, Beukelman T, Gallo L, et al. Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR). J Rheumatol 2008;35:343\u20138.","journal-title":"J Rheumatol"},{"issue":"2 Pt 1","key":"BFpr2013187_CR9","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0022-3476(05)80427-5","volume":"120","author":"R Schneider","year":"1992","unstructured":"Schneider R, Lang BA, Reilly BJ, et al. Prognostic indicators of joint destruction in systemic-onset juvenile rheumatoid arthritis. J Pediatr 1992;120(2 Pt 1):200\u20135.","journal-title":"J Pediatr"},{"key":"BFpr2013187_CR10","first-page":"1989","volume":"29","author":"K Oen","year":"2002","unstructured":"Oen K, Malleson PN, Cabral DA, Rosenberg AM, Petty RE, Cheang M . Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort. J Rheumatol 2002;29:1989\u201399.","journal-title":"J Rheumatol"},{"key":"BFpr2013187_CR11","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1002\/art.21774","volume":"54","author":"D Singh-Grewal","year":"2006","unstructured":"Singh-Grewal D, Schneider R, Bayer N, Feldman BM . Predictors of disease course and remission in systemic juvenile idiopathic arthritis: significance of early clinical and laboratory features. Arthritis Rheum 2006;54:1595\u2013601.","journal-title":"Arthritis Rheum"},{"key":"BFpr2013187_CR12","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1002\/art.24601","volume":"60","author":"MG Barnes","year":"2009","unstructured":"Barnes MG, Grom AA, Thompson SD, et al. Subtype-specific peripheral blood gene expression profiles in recent-onset juvenile idiopathic arthritis. Arthritis Rheum 2009;60:2102\u201312.","journal-title":"Arthritis Rheum"},{"key":"BFpr2013187_CR13","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1136\/ard.2006.061853","volume":"66","author":"W de Jager","year":"2007","unstructured":"de Jager W, Hoppenreijs EP, Wulffraat NM, Wedderburn LR, Kuis W, Prakken BJ . Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study. Ann Rheum Dis 2007;66:589\u201398.","journal-title":"Ann Rheum Dis"},{"key":"BFpr2013187_CR14","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1002\/art.22644","volume":"56","author":"EM Ogilvie","year":"2007","unstructured":"Ogilvie EM, Khan A, Hubank M, Kellam P, Woo P . Specific gene expression profiles in systemic juvenile idiopathic arthritis. Arthritis Rheum 2007;56:1954\u201365.","journal-title":"Arthritis Rheum"},{"key":"BFpr2013187_CR15","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1002\/art.1780340912","volume":"34","author":"F de Benedetti","year":"1991","unstructured":"de Benedetti F, Massa M, Robbioni P, Ravelli A, Burgio GR, Martini A . Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis. Arthritis Rheum 1991;34:1158\u201363.","journal-title":"Arthritis Rheum"},{"key":"BFpr2013187_CR16","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1182\/blood.V87.11.4824.bloodjournal87114824","volume":"87","author":"M Cazzola","year":"1996","unstructured":"Cazzola M, Ponchio L, de Benedetti F, et al. Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis. Blood 1996;87:4824\u201330.","journal-title":"Blood"},{"key":"BFpr2013187_CR17","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1002\/art.22175","volume":"54","author":"F De Benedetti","year":"2006","unstructured":"De Benedetti F, Rucci N, Del Fattore A, et al. Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system. Arthritis Rheum 2006;54:3551\u201363.","journal-title":"Arthritis Rheum"},{"key":"BFpr2013187_CR18","doi-asserted-by":"publisher","first-page":"4818","DOI":"10.1210\/endo.142.11.8511","volume":"142","author":"F De Benedetti","year":"2001","unstructured":"De Benedetti F, Meazza C, Oliveri M, et al. Effect of IL-6 on IGF binding protein-3: a study in IL-6 transgenic mice and in patients with systemic juvenile idiopathic arthritis. Endocrinology 2001;142:4818\u201326.","journal-title":"Endocrinology"},{"key":"BFpr2013187_CR19","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1084\/jem.20050473","volume":"201","author":"V Pascual","year":"2005","unstructured":"Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J . Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 2005;201:1479\u201386.","journal-title":"J Exp Med"},{"key":"BFpr2013187_CR20","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1002\/art.22981","volume":"56","author":"N Fall","year":"2007","unstructured":"Fall N, Barnes M, Thornton S, et al. Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome. Arthritis Rheum 2007;56:3793\u2013804.","journal-title":"Arthritis Rheum"},{"key":"BFpr2013187_CR21","first-page":"823","volume":"34","author":"AP Lotito","year":"2007","unstructured":"Lotito AP, Campa A, Silva CA, Kiss MH, Mello SB . Interleukin 18 as a marker of disease activity and severity in patients with juvenile idiopathic arthritis. J Rheumatol 2007;34:823\u201330.","journal-title":"J Rheumatol"},{"key":"BFpr2013187_CR22","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.cyto.2012.11.025","volume":"61","author":"M Shimizu","year":"2013","unstructured":"Shimizu M, Nakagishi Y, Yachie A . Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles. Cytokine 2013;61:345\u20138.","journal-title":"Cytokine"},{"key":"BFpr2013187_CR23","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S0022-3476(85)80072-X","volume":"106","author":"M Hadchouel","year":"1985","unstructured":"Hadchouel M, Prieur AM, Griscelli C . Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection. J Pediatr 1985;106:561\u20136.","journal-title":"J Pediatr"},{"key":"BFpr2013187_CR24","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1093\/rheumatology\/40.11.1285","volume":"40","author":"JL St\u00e9phan","year":"2001","unstructured":"St\u00e9phan JL, Kon\u00e9-Paut I, Galambrun C, Mouy R, Bader-Meunier B, Prieur AM . Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology (Oxford) 2001;40:1285\u201392.","journal-title":"Rheumatology (Oxford)"},{"key":"BFpr2013187_CR25","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1136\/adc.85.5.421","volume":"85","author":"S Sawhney","year":"2001","unstructured":"Sawhney S, Woo P, Murray KJ . Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child 2001;85:421\u20136.","journal-title":"Arch Dis Child"},{"key":"BFpr2013187_CR26","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/art.22416","volume":"56","author":"J Bleesing","year":"2007","unstructured":"Bleesing J, Prada A, Siegel DM, et al. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis Rheum 2007;56:965\u201371.","journal-title":"Arthritis Rheum"},{"key":"BFpr2013187_CR27","first-page":"1133","volume":"34","author":"EM Behrens","year":"2007","unstructured":"Behrens EM, Beukelman T, Paessler M, Cron RQ . Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol 2007;34:1133\u20138.","journal-title":"J Rheumatol"},{"key":"BFpr2013187_CR28","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/art.23199","volume":"58","author":"MM Hazen","year":"2008","unstructured":"Hazen MM, Woodward AL, Hofmann I, et al. Mutations of the hemophagocytic lymphohistiocytosis-associated gene UNC13D in a patient with systemic juvenile idiopathic arthritis. Arthritis Rheum 2008;58:567\u201370.","journal-title":"Arthritis Rheum"},{"key":"BFpr2013187_CR29","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1002\/art.23734","volume":"58","author":"K Zhang","year":"2008","unstructured":"Zhang K, Biroschak J, Glass DN, et al. Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms. Arthritis Rheum 2008;58:2892\u20136.","journal-title":"Arthritis Rheum"},{"key":"BFpr2013187_CR30","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1067\/mpd.2003.110","volume":"142","author":"AA Grom","year":"2003","unstructured":"Grom AA, Villanueva J, Lee S, Goldmuntz EA, Passo MH, Filipovich A . Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome. J Pediatr 2003;142:292\u20136.","journal-title":"J Pediatr"},{"key":"BFpr2013187_CR31","first-page":"451","volume":"11","author":"JL St\u00e9phan","year":"1993","unstructured":"St\u00e9phan JL, Zeller J, Hubert P, Herbelin C, Dayer JM, Prieur AM . Macrophage activation syndrome and rheumatic disease in childhood: a report of four new cases. Clin Exp Rheumatol 1993;11:451\u20136.","journal-title":"Clin Exp Rheumatol"},{"key":"BFpr2013187_CR32","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S0022-3476(96)70160-9","volume":"129","author":"R Mouy","year":"1996","unstructured":"Mouy R, Stephan JL, Pillet P, Haddad E, Hubert P, Prieur AM . Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases. J Pediatr 1996;129:750\u20134.","journal-title":"J Pediatr"},{"key":"BFpr2013187_CR33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/MPH.0b013e3181923cb4","volume":"31","author":"AA Gupta","year":"2009","unstructured":"Gupta AA, Tyrrell P, Valani R, Benseler S, Abdelhaleem M, Weitzman S . Experience with hemophagocytic lymphohistiocytosis\/macrophage activation syndrome at a single institution. J Pediatr Hematol Oncol 2009;31:81\u20134.","journal-title":"J Pediatr Hematol Oncol"},{"key":"BFpr2013187_CR34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.clim.2009.02.005","volume":"132","author":"A Coca","year":"2009","unstructured":"Coca A, Bundy KW, Marston B, Huggins J, Looney RJ . Macrophage activation syndrome: serological markers and treatment with anti-thymocyte globulin. Clin Immunol 2009;132:10\u20138.","journal-title":"Clin Immunol"},{"key":"BFpr2013187_CR35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/RHU.0b013e318205092d","volume":"17","author":"N Bruck","year":"2011","unstructured":"Bruck N, Suttorp M, Kabus M, Heubner G, Gahr M, Pessler F . Rapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroids. J Clin Rheumatol 2011;17:23\u20137.","journal-title":"J Clin Rheumatol"},{"key":"BFpr2013187_CR36","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/art.30128","volume":"63","author":"PA Nigrovic","year":"2011","unstructured":"Nigrovic PA, Mannion M, Prince FH, et al. Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series. Arthritis Rheum 2011;63:545\u201355.","journal-title":"Arthritis Rheum"},{"key":"BFpr2013187_CR37","first-page":"533","volume":"151","author":"C Larroche","year":"2000","unstructured":"Larroche C, Bruneel F, Andr\u00e9 MH, et al.; Comit\u00e9 d\u2019Evaluation et de Diffusion des Innovation Technologiques (CEDIT). [Intravenously administered gamma-globulins in reactive hemaphagocytic syndrome. Multicenter study to assess their importance, by the immunoglobulins group of experts of CEDIT of the AP-HP]. Ann Med Interne (Paris) 2000;151:533\u20139.","journal-title":"Ann Med Interne (Paris)"},{"key":"BFpr2013187_CR38","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/MPH.0b013e3180f61be3","volume":"29","author":"NJ Balamuth","year":"2007","unstructured":"Balamuth NJ, Nichols KE, Paessler M, Teachey DT . Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis. J Pediatr Hematol Oncol 2007;29:569\u201373.","journal-title":"J Pediatr Hematol Oncol"},{"key":"BFpr2013187_CR39","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007;48:124\u201331.","journal-title":"Pediatr Blood Cancer"},{"key":"BFpr2013187_CR40","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1002\/1529-0131(200008)43:8<1849::AID-ANR22>3.0.CO;2-F","volume":"43","author":"P Woo","year":"2000","unstructured":"Woo P, Southwood TR, Prieur AM, et al. Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis. Arthritis Rheum 2000;43:1849\u201357.","journal-title":"Arthritis Rheum"},{"key":"BFpr2013187_CR41","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1093\/rheumatology\/40.8.907","volume":"40","author":"V Gerloni","year":"2001","unstructured":"Gerloni V, Cimaz R, Gattinara M, Arnoldi C, Pontikaki I, Fantini F . Efficacy and safety profile of cyclosporin A in the treatment of juvenile chronic (idiopathic) arthritis. Results of a 10-year prospective study. Rheumatology (Oxford) 2001;40:907\u201313.","journal-title":"Rheumatology (Oxford)"},{"key":"BFpr2013187_CR42","first-page":"599","volume":"24","author":"N Ruperto","year":"2006","unstructured":"Ruperto N, Ravelli A, Castell E, et al.; Pediatric Rheumatology Collaborative Study Group (PRCSG); Paediatric Rheumatology International Trials Organisation (PRINTO). Cyclosporine A in juvenile idiopathic arthritis. Results of the PRCSG\/PRINTO phase IV post marketing surveillance study. Clin Exp Rheumatol 2006;24:599\u2013605.","journal-title":"Clin Exp Rheumatol"},{"key":"BFpr2013187_CR43","first-page":"2353","volume":"21","author":"ED Silverman","year":"1994","unstructured":"Silverman ED, Cawkwell GD, Lovell DJ, et al. Intravenous immunoglobulin in the treatment of systemic juvenile rheumatoid arthritis: a randomized placebo controlled trial. Pediatric Rheumatology Collaborative Study Group. J Rheumatol 1994;21:2353\u20138.","journal-title":"J Rheumatol"},{"key":"BFpr2013187_CR44","first-page":"910","volume":"23","author":"Y Uziel","year":"1996","unstructured":"Uziel Y, Laxer RM, Schneider R, Silverman ED . Intravenous immunoglobulin therapy in systemic onset juvenile rheumatoid arthritis: a followup study. J Rheumatol 1996;23:910\u20138.","journal-title":"J Rheumatol"},{"key":"BFpr2013187_CR45","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.jpeds.2004.08.020","volume":"145","author":"TJ Lehman","year":"2004","unstructured":"Lehman TJ, Schechter SJ, Sundel RP, Oliveira SK, Huttenlocher A, Onel KB . Thalidomide for severe systemic onset juvenile rheumatoid arthritis: A multicenter study. J Pediatr 2004;145:856\u20137.","journal-title":"J Pediatr"},{"key":"BFpr2013187_CR46","first-page":"2696","volume":"27","author":"W Breit","year":"2000","unstructured":"Breit W, Frosch M, Meyer U, Heinecke A, Ganser G . A subgroup-specific evaluation of the efficacy of intraarticular triamcinolone hexacetonide in juvenile chronic arthritis. J Rheumatol 2000;27:2696\u2013702.","journal-title":"J Rheumatol"},{"key":"BFpr2013187_CR47","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3899\/jrheum.090952","volume":"36","author":"RA Russo","year":"2009","unstructured":"Russo RA, Katsicas MM . Clinical remission in patients with systemic juvenile idiopathic arthritis treated with anti-tumor necrosis factor agents. J Rheumatol 2009;36:1078\u201382.","journal-title":"J Rheumatol"},{"key":"BFpr2013187_CR48","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1542\/pir.33-7-303","volume":"33","author":"M Espinosa","year":"2012","unstructured":"Espinosa M, Gottlieb BS . Juvenile idiopathic arthritis. Pediatr Rev 2012;33:303\u201313.","journal-title":"Pediatr Rev"},{"key":"BFpr2013187_CR49","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/art.20033","volume":"50","author":"PN Hawkins","year":"2004","unstructured":"Hawkins PN, Lachmann HJ, Aganna E, McDermott MF . Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum 2004;50:607\u201312.","journal-title":"Arthritis Rheum"},{"key":"BFpr2013187_CR50","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1056\/NEJMoa055137","volume":"355","author":"R Goldbach-Mansky","year":"2006","unstructured":"Goldbach-Mansky R, Dailey NJ, Canna SW, et al. Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J Med 2006;355:581\u201392.","journal-title":"N Engl J Med"},{"key":"BFpr2013187_CR51","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/S0140-6736(04)17401-1","volume":"364","author":"HM Hoffman","year":"2004","unstructured":"Hoffman HM, Rosengren S, Boyle DL, et al. Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet 2004;364:1779\u201385.","journal-title":"Lancet"},{"key":"BFpr2013187_CR52","first-page":"2071","volume":"31","author":"JW Verbsky","year":"2004","unstructured":"Verbsky JW, White AJ . Effective use of the recombinant interleukin 1 receptor antagonist anakinra in therapy resistant systemic onset juvenile rheumatoid arthritis. J Rheumatol 2004;31:2071\u20135.","journal-title":"J Rheumatol"},{"key":"BFpr2013187_CR53","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1002\/1529-0131(199707)40:7<1202::AID-ART3>3.0.CO;2-R","volume":"40","author":"EH Giannini","year":"1997","unstructured":"Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A . Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997;40:1202\u20139.","journal-title":"Arthritis Rheum"},{"key":"BFpr2013187_CR54","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1136\/ard.2010.134254","volume":"70","author":"P Quartier","year":"2011","unstructured":"Quartier P, Allantaz F, Cimaz R, et al. A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial). Ann Rheum Dis 2011;70:747\u201354.","journal-title":"Ann Rheum Dis"},{"key":"BFpr2013187_CR55","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/art.33342","volume":"64","author":"N Ruperto","year":"2012","unstructured":"Ruperto N, Quartier P, Wulffraat N, et al.; Paediatric Rheumatology International Clinical Trials Organisation. A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features. Arthritis Rheum 2012;64:557\u201367.","journal-title":"Arthritis Rheum"},{"key":"BFpr2013187_CR56","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1056\/NEJMoa1205099","volume":"367","author":"N Ruperto","year":"2012","unstructured":"Ruperto N, Brunner HI, Quartier P, et al.; PRINTO; PRCSG. Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. N Engl J Med 2012;367:2396\u2013406.","journal-title":"N Engl J Med"},{"key":"BFpr2013187_CR57","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1002\/art.23620","volume":"58","author":"R Goldbach-Mansky","year":"2008","unstructured":"Goldbach-Mansky R, Shroff SD, Wilson M, et al. A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome. Arthritis Rheum 2008;58:2432\u201342.","journal-title":"Arthritis Rheum"},{"key":"BFpr2013187_CR58","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1002\/art.23687","volume":"58","author":"HM Hoffman","year":"2008","unstructured":"Hoffman HM, Throne ML, Amar NJ, et al. Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies. Arthritis Rheum 2008;58:2443\u201352.","journal-title":"Arthritis Rheum"},{"key":"BFpr2013187_CR59","doi-asserted-by":"publisher","first-page":"533","DOI":"10.7326\/0003-4819-157-8-201210160-00003","volume":"157","author":"PJ Hashkes","year":"2012","unstructured":"Hashkes PJ, Spalding SJ, Giannini EH, et al. Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trial. Ann Intern Med 2012;157:533\u201341.","journal-title":"Ann Intern Med"},{"key":"BFpr2013187_CR60","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1136\/annrheumdis-2012-201409","volume":"71","author":"O Petryna","year":"2012","unstructured":"Petryna O, Cush JJ, Efthimiou P . IL-1 Trap rilonacept in refractory adult onset Still\u2019s disease. Ann Rheum Dis 2012;71:2056\u20137.","journal-title":"Ann Rheum Dis"},{"key":"BFpr2013187_CR61","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1002\/art.21956","volume":"54","author":"DJ Lovell","year":"2006","unstructured":"Lovell DJ, Glass D, Ranz J, et al. A randomized controlled trial of calcium supplementation to increase bone mineral density in children with juvenile rheumatoid arthritis. Arthritis Rheum 2006;54:2235\u201342.","journal-title":"Arthritis Rheum"},{"key":"BFpr2013187_CR62","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1002\/art.20944","volume":"52","author":"S Yokota","year":"2005","unstructured":"Yokota S, Miyamae T, Imagawa T, et al. Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2005;52:818\u201325.","journal-title":"Arthritis Rheum"},{"key":"BFpr2013187_CR63","doi-asserted-by":"publisher","first-page":"R1281","DOI":"10.1186\/ar1826","volume":"7","author":"P Woo","year":"2005","unstructured":"Woo P, Wilkinson N, Prieur AM, et al. Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement. Arthritis Res Ther 2005;7:R1281\u20138.","journal-title":"Arthritis Res Ther"},{"key":"BFpr2013187_CR64","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/S0140-6736(08)60454-7","volume":"371","author":"S Yokota","year":"2008","unstructured":"Yokota S, Imagawa T, Mori M, et al. Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial. Lancet 2008;371:998\u20131006.","journal-title":"Lancet"},{"key":"BFpr2013187_CR65","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","volume":"367","author":"F De Benedetti","year":"2012","unstructured":"De Benedetti F, Brunner HI, Ruperto N, et al.; PRINTO; PRCSG. Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. N Engl J Med 2012;367:2385\u201395.","journal-title":"N Engl J Med"},{"key":"BFpr2013187_CR66","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/acr.21625","volume":"64","author":"EM DeWitt","year":"2012","unstructured":"DeWitt EM, Kimura Y, Beukelman T, et al.; Juvenile Idiopathic Arthritis Disease-specific Research Committee of Childhood Arthritis Rheumatology and Research Alliance. Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 2012;64:1001\u201310.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"BFpr2013187_CR67","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1002\/art.27431","volume":"62","author":"N Ruperto","year":"2010","unstructured":"Ruperto N, Lovell DJ, Quartier P, et al.; Paediatric Rheumatology International Trials Organization and the Pediatric Rheumatology Collaborative Study Group. Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis. Arthritis Rheum 2010;62:1792\u2013802.","journal-title":"Arthritis Rheum"},{"key":"BFpr2013187_CR68","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3899\/jrheum.100726","volume":"38","author":"JL Record","year":"2011","unstructured":"Record JL, Beukelman T, Cron RQ . Combination therapy of abatacept and anakinra in children with refractory systemic juvenile idiopathic arthritis: a retrospective case series. J Rheumatol 2011;38:180\u20131.","journal-title":"J Rheumatol"},{"key":"BFpr2013187_CR69","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1038\/sj.bmt.1703946","volume":"32:Suppl 1","author":"NM Wulffraat","year":"2003","unstructured":"Wulffraat NM, Brinkman D, Ferster A, et al. Long-term follow-up of autologous stem cell transplantation for refractory juvenile idiopathic arthritis. Bone Marrow Transplant 2003;32:Suppl 1:S61\u20134.","journal-title":"Bone Marrow Transplant"},{"key":"BFpr2013187_CR70","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1002\/art.22656","volume":"56","author":"DM Brinkman","year":"2007","unstructured":"Brinkman DM, de Kleer IM, ten Cate R, et al. Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial. Arthritis Rheum 2007;56:2410\u201321.","journal-title":"Arthritis Rheum"},{"key":"BFpr2013187_CR71","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.molimm.2008.12.029","volume":"47","author":"M Abinun","year":"2009","unstructured":"Abinun M, Flood TJ, Cant AJ, et al. Autologous T cell depleted haematopoietic stem cell transplantation in children with severe juvenile idiopathic arthritis in the UK (2000-2007). Mol Immunol 2009;47:46\u201351.","journal-title":"Mol Immunol"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/pr2013187.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr2013187","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr2013187.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T09:17:31Z","timestamp":1716110251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pr2013187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,8]]},"references-count":71,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["BFpr2013187"],"URL":"https:\/\/doi.org\/10.1038\/pr.2013.187","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,8]]}}}